Artiva Biotherapeutics, Inc. - ARTV
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 28, 2026 | SCHEDULE 13D/A | — | — | — | View |
| May 18, 2026 | SCHEDULE 13G | VIKING GLOBAL INVESTORS LP | 5.4% | 2,604,166 | View |
| May 18, 2026 | SCHEDULE 13G | Viking Global Opportunities Parent GP LLC | 5.4% | 2,604,166 | View |
| May 18, 2026 | SCHEDULE 13G | Viking Global Opportunities GP LLC | 3.8% | 1,822,916 | View |
| May 18, 2026 | SCHEDULE 13G | Viking Global Opportunities Portfolio GP LLC | 3.8% | 1,822,916 | View |
| May 18, 2026 | SCHEDULE 13G | Viking Global Opportunities Illiquid Investments Sub-Master LP | 3.8% | 1,822,916 | View |
| May 18, 2026 | SCHEDULE 13G | Viking Global Opportunities Vintage IV GP LLC | 1.6% | 781,250 | View |
| May 18, 2026 | SCHEDULE 13G | Viking Global Opportunities Vintage IV Portfolio GP LLC | 1.6% | 781,250 | View |
| May 18, 2026 | SCHEDULE 13G | Viking Global Opportunities Vintage IV (Aggregator) LP | 1.6% | 781,250 | View |
| May 18, 2026 | SCHEDULE 13G | HALVORSEN OLE ANDREAS | 5.4% | 2,604,166 | View |
| May 18, 2026 | SCHEDULE 13G | Shabet Rose Sharon | 5.4% | 2,604,166 | View |
| May 13, 2026 | SCHEDULE 13D/A | — | 9.99% | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.